Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel Aghion currently holds 38,820 shares of ORAMED PHARMACEUTICALS INC. (ORMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Aghion has been a net neutral trader of ORMP stock. They have purchased $0 and sold $0 worth of shares.
Daniel Aghion's most recent insider trade was on Jan 30, 2024, when they sold 3,750 shares at $0.00 per share.
Daniel Aghion serves as Executive at ORAMED PHARMACEUTICALS INC. (ORMP). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Daniel Aghion holds the position of Executive at ORAMED PHARMACEUTICALS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Daniel Aghion has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Daniel Aghion was on Jan 30, 2024, when they purchased $0 worth of ORMP shares. This transaction involved 3,750 shares at N/A per share.
Daniel Aghion currently owns 38,820 shares of ORAMED PHARMACEUTICALS INC. (ORMP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel Aghion's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel Aghion has 3 Form 4 filings on record as an insider at ORAMED PHARMACEUTICALS INC..
Set alerts for Daniel Aghion and 40,000+ other insiders.